Results 231 to 240 of about 2,312,760 (293)
ABSTRACT Introduction Relapsed/refractory post‐transplant lymphoproliferative disorder (PTLD) remains a challenging complication after solid organ transplantation (SOT), requiring complex balancing of immune‐suppressive therapy (IST) and lymphoma‐directed therapies. Methods We report the case of a 40‐year‐old female kidney‐pancreas transplant recipient
Maria Mappoura +21 more
wiley +1 more source
Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang +16 more
wiley +1 more source
Tocilizumab Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney Transplantation. [PDF]
Huang E +7 more
europepmc +1 more source
Abstract 5‐Methylcytidine (m5C) modifications play a critical role in RNA metabolism. TRM4B (tRNA‐specific methytransferase 4B) is the only known component of the plant m5C machinery that mediates mRNA (messenger RNA) methylation. To date, no regulators governing site‐specific m5C modifications have been identified, apart from several degenerated ...
Zedi Feng +6 more
wiley +1 more source
Lipoprotein X-Induced Hyperlipidemia Following Liver Transplantation in the Setting of Persistent Cholestasis and Antibody-Mediated Rejection. [PDF]
Antony I, Kapoor A, Zhan Y, Lin MV.
europepmc +1 more source
Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection. [PDF]
Madill-Thomsen KS +11 more
europepmc +1 more source
Anti-CD38 and Regression of Chronic Active Antibody-Mediated Rejection After Kidney Transplantation - Myth or Reality? [PDF]
Matignon M +3 more
europepmc +1 more source

